- Home
- ITOS vs ANGO Comparison
ITOS vs ANGO Comparison
Compare ITOS & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITOS
- ANGO
- Stock Information
- Founded
- ITOS 2011
- ANGO 1988
- Country
- ITOS United States
- ANGO United States
- Employees
- ITOS N/A
- ANGO N/A
- Industry
- ITOS Biotechnology: Biological Products (No Diagnostic Substances)
- ANGO Medical/Dental Instruments
- Sector
- ITOS Health Care
- ANGO Health Care
- Exchange
- ITOS Nasdaq
- ANGO Nasdaq
- Market Cap
- ITOS 271.1M
- ANGO 279.1M
- IPO Year
- ITOS 2020
- ANGO 2004
- Fundamental
- Price
- ITOS $7.41
- ANGO $9.01
- Analyst Decision
- ITOS Strong Buy
- ANGO Strong Buy
- Analyst Count
- ITOS 3
- ANGO 4
- Target Price
- ITOS $21.33
- ANGO $12.00
- AVG Volume (30 Days)
- ITOS 512.7K
- ANGO 589.7K
- Earning Date
- ITOS 11-12-2024
- ANGO 01-08-2025
- Dividend Yield
- ITOS N/A
- ANGO N/A
- EPS Growth
- ITOS N/A
- ANGO N/A
- EPS
- ITOS N/A
- ANGO N/A
- Revenue
- ITOS $35,000,000.00
- ANGO $292,726,000.00
- Revenue This Year
- ITOS $271.18
- ANGO N/A
- Revenue Next Year
- ITOS N/A
- ANGO $7.69
- P/E Ratio
- ITOS N/A
- ANGO N/A
- Revenue Growth
- ITOS N/A
- ANGO N/A
- 52 Week Low
- ITOS $7.09
- ANGO $5.26
- 52 Week High
- ITOS $18.75
- ANGO $9.58
- Technical
- Relative Strength Index (RSI)
- ITOS 36.39
- ANGO 64.08
- Support Level
- ITOS $7.09
- ANGO $8.59
- Resistance Level
- ITOS $7.53
- ANGO $9.58
- Average True Range (ATR)
- ITOS 0.37
- ANGO 0.55
- MACD
- ITOS -0.02
- ANGO -0.00
- Stochastic Oscillator
- ITOS 21.28
- ANGO 78.57
About ITOS iTeos Therapeutics Inc.
ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.
About ANGO AngioDynamics Inc.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.